Fentanyl Infusion Dosing for Sedation in 18kg Pediatric Patient
For continuous fentanyl infusion in an 18kg pediatric patient requiring sedation, start with 1-2 mcg/kg/h (18-36 mcg/h) after an initial bolus of 1-2 mcg/kg (18-36 mcg), titrating based on clinical response while monitoring closely for respiratory depression. 1
Initial Dosing Strategy
Bolus Dose
- Administer 1-2 mcg/kg IV (18-36 mcg for this 18kg patient) over several minutes
- For intubation or acute procedural sedation, higher boluses of 1-5 mcg/kg may be used 1
- Critical warning: Rapid administration can cause chest wall and glottic rigidity even at low doses; titrate slowly over several minutes unless a muscle relaxant is co-administered 1
Continuous Infusion
- Standard starting rate: 1-5 mcg/kg/h (18-90 mcg/h for this patient) 1
- For general sedation in mechanically ventilated children, typical range is 1-5 mcg/kg/h 2
- Adult cardiac arrest guidelines suggest 25-300 mcg/h (0.5-5 mcg/kg/h), which translates to similar weight-based dosing 3
Titration and Monitoring
Reassess sedation level every 5 minutes initially, then adjust monitoring intervals based on stability 4. The effect of any dose change should be re-evaluated based on fentanyl's half-life and clinical response 2.
Key Monitoring Parameters
- Continuous pulse oximetry is mandatory 1
- Respiratory rate and effort
- Level of sedation
- Hemodynamic stability (blood pressure, heart rate)
- Signs of chest wall rigidity
Titration Guidelines
- Increase by 0.5-1 mcg/kg/h increments based on inadequate sedation
- Maximum doses in pediatric studies have reached 3.9 mcg/kg/h (median dose in critically ill children) 5
- Higher doses may be required in burn patients or those with opioid tolerance 1
Critical Safety Considerations
Respiratory Depression Risk
Fentanyl's primary hazard is respiratory depression, especially when combined with benzodiazepines or other sedatives 1. The risk increases significantly with:
- Co-administration of midazolam or other benzodiazepines
- Rapid bolus administration
- Inadequate monitoring
- Sleep state (delayed effects may occur hours after administration) 6
Pharmacokinetic Considerations in Children
- Elimination half-life in newborns: 9.5 hours (range 5.7-12.7 hours) 7
- Volume of distribution is larger in children than adults (17 L/kg in newborns) 7
- Total body clearance correlates with postnatal age 7
- These factors mean prolonged effects and accumulation risk with continuous infusions
Reversal Agent Availability
Have naloxone immediately available: 0.1 mg/kg IV/IM (for children <5 years or <20kg) 1. Use lower doses (1-15 mcg/kg) to reverse therapeutic respiratory depression without completely eliminating analgesia 1.
Weaning Protocol
When discontinuing after prolonged infusion (>7 days), do not stop abruptly due to withdrawal risk 8:
- Calculate 24-hour fentanyl dose
- Convert to methadone (fentanyl:methadone ratio = 100:1)
- Divide methadone dose by 8-12 for initial daily dose
- Wean over 10-11 days using structured protocol 8
Alternatively, subcutaneous fentanyl can be used for gradual weaning, decreasing by 1 mcg/kg/h every 12-24 hours 9.
Common Pitfalls to Avoid
- Never use fentanyl as sole sedative: It provides analgesia but minimal anxiolysis. Consider adding propofol or dexmedetomidine if sedation is inadequate 3
- Avoid in hemodynamically unstable patients: Fentanyl can cause hypotension through sympathetic ablation; consider ketamine instead 3
- Do not dose based on total body weight in obese patients: Use ideal body weight 6
- Watch for drug interactions: CYP3A4 inhibitors (e.g., fluconazole, erythromycin) increase fentanyl levels and prolong effects 10
Practical Application for This 18kg Patient
Recommended starting regimen:
- Bolus: 18-36 mcg (1-2 mcg/kg) IV over 2-3 minutes
- Infusion: 18-36 mcg/h (1-2 mcg/kg/h) initially
- Titrate upward by 9-18 mcg/h (0.5-1 mcg/kg/h) every 30-60 minutes as needed
- Maximum typical dose: 70-90 mcg/h (4-5 mcg/kg/h)
- Ensure continuous pulse oximetry and have naloxone at bedside